Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing drug candidates for the treatment of diseases involving mitochondrial dysfunction, today announced that its management team will participate in two upcoming investor conferences. Details of the conferences are as follows:
Help employers find you! Check out all the jobs and post your resume.
